Related Experiment Video
Updated: Jul 1, 2026
09:29
Reprogramming Induced Pluripotent Stem Cell Lines from Frozen Buffy Coat Samples
Published on: April 10, 2026
New paths to pluripotent stem cells
1Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA. Tweedell.1@nd.edu
Current Stem Cell Research & Therapy
|September 11, 2008
Summary
Researchers explored alternative sources for pluripotent stem cells, including embryonic stem cells (ES) and induced pluripotent stem cells (iPS), to overcome limitations in human regenerative medicine.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Developmental biology
Background:
- Embryonic stem cells (ES) are a versatile source of pluripotent cells but face ethical and technical challenges for human therapeutic use.
- Somatic cell nuclear transfer (SCNT) and nuclear transfer (NT) offer tailored stem cells but have limitations regarding oocyte availability and human application.
- Alternative strategies like using single blastomeres, arrested embryos, post-implantation embryos, parthenotes, and cell fusion are being investigated.
Purpose of the Study:
- To review and evaluate various sources of pluripotent stem cells for potential human therapeutic applications.
- To identify the limitations and promise of different stem cell derivation methods.
- To explore advancements in generating patient-specific stem cells.
Main Methods:
- Review of existing literature on stem cell derivation techniques.
- Analysis of methods including isolation of ES cell lines from single blastomeres, use of arrested or post-implantation embryos, somatic cell nuclear transplantation (SCNT), nuclear transfer (NT), parthenogenesis, cell fusion, and reprogramming of adult somatic cells.
- Investigation of induced pluripotent stem cells (iPS) generated via retroviral transduction of transcription factors.
Main Results:
- Embryonic stem cells (ES) offer pluripotency but are limited by ethical and technical concerns.
- Somatic cell nuclear transplantation (SCNT) and nuclear transfer (NT) methods provide donor-specific cells but require oocytes and have restrictions for human reproductive use.
- Induced pluripotent stem cells (iPS) show great promise, derived from adult somatic cells using transcription factors, though all methods have current limitations for extensive human regenerative medicine.
Conclusions:
- Despite advancements, significant technical and ethical hurdles remain for the widespread clinical application of various stem cell sources in human regenerative medicine.
- Induced pluripotent stem cells (iPS) represent a promising avenue, but further research is needed to optimize their safety and efficacy.
- Continued exploration of novel stem cell sources and reprogramming techniques is crucial for the future of regenerative medicine.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:14Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...